SCHEMBL499769

SCHEMBL499769

CCCOP(=S)(OCCC)OP(=S)(OCCC)OCCC

nearest known ligand 0.38

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
TDP1 Q9NUW8 1/20 0.38
LPAR2 Q9HBW0 3/20 0.36
LPAR3 Q9UBY5 3/20 0.36
CYP3A4 P08684 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1975793 0.88 MEN1 (0.46) MEN1KMT2ATDP1LPAR2LPAR3
Ammonia Solution, Strong SCHEMBL5047510 0.81 CYP3A4 (0.48) MEN1KMT2ATDP1LPAR2LPAR3
SCHEMBL10790600 0.81 LPAR3 (0.34) MEN1KMT2ATDP1LPAR2LPAR3
SCHEMBL13020545 0.80 MEN1 (0.37) MEN1KMT2ATDP1LPAR2LPAR3
SCHEMBL8055699 0.78 MEN1 (0.35) MEN1KMT2ATDP1LPAR2LPAR3
Sulfotep SCHEMBL7414347 0.77 TDP1 (0.43) MEN1KMT2ATDP1LPAR2LPAR3
Sulfotep SCHEMBL8191946 0.75 TDP1 (0.46) MEN1KMT2ATDP1CYP3A4
Sulfotep SCHEMBL35637 0.75 TDP1 (0.46) MEN1KMT2ATDP1CYP3A4
Sulfotep SCHEMBL10606468 0.73 TDP1 (0.44) MEN1KMT2ATDP1CYP3A4
Sulfotep SCHEMBL1668626 0.73 TDP1 (0.44) MEN1KMT2ATDP1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1008 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240102976-A1 METHOD FOR SCREENING PESTICIDE RESIDUES IN MEDICINE FOOD HOMOLOGY CHARACTERISTIC AGRICULTUREAL PRODUCTS CHANGCHUN CUSTOMS TECHNOLOGY CENTER (CN) 2024-03-28 US claimed
US-11510929-B2 Mitigation of epileptic seizures by combination therapy using benzodiazepines and neurosteroids THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2022-11-29 US claimed
US-20200396997-A1 A STABLE AGROCHEMICAL COMPOSITION UPL LTD (IN) 2020-12-24 US claimed
US-20200215078-A1 MITIGATION OF EPILEPTIC SEIZURES BY COMBINATION THERAPY USING BENZODIAZEPINES AND NEUROSTEROIDS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2020-07-09 US claimed
WO-2020127319-A1 PLANT GROWTH REGULATOR COMPOSITIONS SYNGENTA CROP PROTECTION AG (CH) 2020-06-25 WO claimed
US-20190327974-A1 SYNERGISTS FOR IMPROVED PESTICIDES THE AUSTRALIAN NATIONAL UNIVERSITY (AU) 2019-10-31 US claimed
CN-110312424-A Synergist for improving pesticide 澳大利亚国立大学 2019-10-08 CN claimed
US-10426786-B2 Mitigation of epileptic seizures by combination therapy using benzodiazepines and neurosteroids THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2019-10-01 US claimed
CN-108896694-B A kind of remaining LC-QToF-MS Screening analysis method of pesticide in animal food 中国农业科学院农业质量标准与检测技术研究所 2019-09-27 CN claimed
WO-2019175701-A1 A STABLE AGROCHEMICAL COMPOSITION UPL LTD (IN) 2019-09-19 WO claimed
JP-2008509189-A 2008-03-27 JP claimed
US-20080070785-A1 For controlling phytopathogenic diseases; synergistic SYNGENTA CROP PROTECTION, INC. (US) 2008-03-20 US claimed
US-20070244121-A1 Synergistic Fungicidal Compositions SYNGENTA CROP PROTECTION, INC. (US) 2007-10-18 US claimed
EP-1802198-A1 SYNERGISTIC FUNGICIDAL COMPOSITIONS Syngeta Participations AG (CH) 2007-07-04 EP claimed
EP-1796464-A1 FUNGICIDAL COMPOSITIONS Syngeta Participations AG (CH) 2007-06-20 EP claimed
EP-1778013-A1 FUNGICIDAL COMPOSITIONS Syngeta Participations AG (CH) 2007-05-02 EP claimed
WO-2007009661-A2 PESTICIDAL MIXTURES CONTAINING BICYCLIC ANTHRANILAMIDES SYNGENTA PARTICIPATIONS AG (CH) 2007-01-25 WO claimed
WO-2006037632-A1 SYNERGISTIC FUNGICIDAL COMPOSITIONS SYNGENTA PARTICIPATIONS AG (CH) 2006-04-13 WO claimed
WO-2006037634-A1 FUNGICIDAL COMPOSITIONS SYNGENTA PARTICIPATIONS AG (CH) 2006-04-13 WO claimed
WO-2006015865-A1 FUNGICIDAL COMPOSITIONS SYNGENTA PARTICIPATIONS AG (CH) 2006-02-16 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11510929-B2 Mitigation of epileptic seizures by combination therapy using benzodiazepines and neurosteroids GABRB2, GABRA4, GABRB1 MEN1 1278/4885KMT2A 832/4885TDP1 4529/4885
US-20190327974-A1 SYNERGISTS FOR IMPROVED PESTICIDES BCHE, DDT, DBF4 MEN1 604/4885KMT2A 1397/4885TDP1 3197/4885
US-10426786-B2 Mitigation of epileptic seizures by combination therapy using benzodiazepines and neurosteroids GABRB2, GABRA4, GABRB1 MEN1 1278/4885KMT2A 832/4885TDP1 4529/4885
US-20070244121-A1 Synergistic Fungicidal Compositions DDT, CRY1, HCN1 MEN1 337/4885KMT2A 2009/4885TDP1 1332/4885
US-20200215078-A1 MITIGATION OF EPILEPTIC SEIZURES BY COMBINATION THERAPY USING BENZODIAZEPINES AND NEUROSTEROIDS GABRB2, GABRA4, GABRB1 MEN1 1278/4885KMT2A 832/4885TDP1 4529/4885
US-20080070785-A1 For controlling phytopathogenic diseases; synergistic BROX, EPM2A, MANBA MEN1 927/4885KMT2A 3493/4885TDP1 2299/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.